Skip to main content
. 2021 Aug 10;114(5):1655–1665. doi: 10.1093/ajcn/nqab243

TABLE 1.

Clinical characteristics of the 457 DIETFITS (Diet Intervention Examining the Factors Interacting with Treatment Success) study participants by examination phase1

Examination 1 (baseline) Examination 2 (6-mo follow-up) P value
Anthropometrics
 Age, y 39.8 ± 6.6
 Body weight, kg 95.7 ± 14.8 88.4 ± 14.3 <0.0001
 Body height, cm 169.3 ± 9.5
 BMI, kg/m2 33.3 ± 3.6 30.8 ± 3.7 <0.0001
 Systolic BP, mm Hg 123.8 ± 12.5 119.3 ± 11.5 <0.0001
 Diastolic BP, mm Hg 81.3 ± 7.6 78.3 ± 7.3 <0.0001
 Heart rate, bpm 70.4 ± 10.1 67.5 ± 10.1 <0.0001
Biochemical data
 HOMA-IR 3.26 (1.71–7.26) 2.26 (1.43–6.39) <0.0001
 Total cholesterol, mg/dL 189.2 ± 33.9 183.6 ± 35.1 <0.0001
 LDL cholesterol, mg/dL 114.2 ± 28.9 113.2 ± 29.7 0.32
 HDL cholesterol, mg/dL 48.9 ± 9.8 49.2 ± 9.6 0.31
 Triglycerides, mg/dL 113.1 (64.9–223.0) 92.5 (54.5–180.5) <0.0001
 sACE2, NPX 1.89 ± 0.63 1.74 ± 0.54 <0.0001
Race/ethnicity
 White 328 (71.8)
 Black/African American 14 (3.1)
 Asian 48 (10.5)
 Other 67 (14.7)
DXA scan2
 BMC mass, kg 2.59 ± 0.44 2.59 ± 0.44 0.45
 Fat mass, kg 33.4 ± 7.5 28.8 ± 8.0 <0.0001
 Lean mass, kg 56.0 ± 11.3 54.1 ± 10.8 <0.0001
 Fat percentage, % 36.5 ± 6.8 33.7 ± 7.6 <0.0001

1Values are arithmetic mean ± SD, geometric mean (10th–90th percentile), or participant n (%). P values reflect the significance of 6-mo longitudinal changes according to a paired-sample t test. BMC, bone mineral content; BP, blood pressure; NPX, Normalized Protein eXpression; sACE2, soluble angiotensin-converting enzyme 2.

2Baseline and follow-up data for DXA scan measurements were available in 352 participants.